Rhythm-sponsored satellite symposium at ECE 2026

Sunday, 10 May 2026, Prague - Czech Republic

Recording available soon

Rhythm-sponsored satellite symposium at ECE 2026

Advancing care in rare melanocortin-4 receptor (MC4R) pathway diseases: Focus on Bardet-Biedl syndrome (BBS)

During this session, Professor Philip Beales (University College London, United Kingdom), Professor Matthias Blüher (University of Leipzig, Germany) and Dr Pauline Faucher (Assistance Publique des Hôpitaux de Paris, France) discussed:

  • Rare hypothalamic MC4R pathway diseases
  • Early-onset obesity and urgency to treat
  • Real-world evidence in BBS

Rare hypothalamic MC4R pathway diseases

Prof. Philip Beales

Please login or signup to unlock the videos

Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.

LoginSignup

Early-onset obesity and urgency to treat

Prof. Matthias Blüher

Please login or signup to unlock the videos

Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.

LoginSignup

Real-world evidence in BBS

Dr Pauline Faucher

Please login or signup to unlock the videos

Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.

LoginSignup

Speakers:

Prof. Philip Beales

(UK)

Prof. Matthias Blüher

(Germany)

Dr Pauline Faucher

(France)